LoadingLoadingLoadingNo insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (3)
Citadel
$68.0M
bought
Qube Research
$28.2M
added
JPMorgan Chase
$13.6M
added
No tracked top-trader positions in GMAB as of Oct 24, 10:04 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.37 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 24, 2026
EPS expected
$0.24 to $0.36
Revenue expected
12 analysts
Last 30 days
Split both ways
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $0.54 / $0.37Alpha Vantage | +45.95% beat | $1.16B No estimate | Unavailable |
| Mar 31, 2026 | May 7, 2026 | $0.13 / $0.19Yahoo Finance | -29.74% miss | $899.3M No estimate | Unavailable |
| Dec 31, 2025 | Feb 17, 2026 | $0.21 / $0.37Yahoo Finance | -44.55% miss | $1.05B No estimate | Unavailable |
| Sep 30, 2025 | Nov 6, 2025 | $0.65 / $0.45Yahoo Finance | +42.31% beat | $1.02B No estimate | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $0.54 / $0.39Alpha Vantage | +38.46% beat | $924.8M No estimate | Unavailable |
| Mar 31, 2025 | May 8, 2025 | $0.31 / $0.23Alpha Vantage | +34.78% beat | DKK 105.2M No estimate | Unavailable |
| Dec 31, 2024 | Feb 12, 2025 | $0.84 / $0.28Alpha Vantage | +$0.56 beat | DKK 6.44B No estimate | Unavailable |
| Sep 30, 2024 | Nov 6, 2024 | $0.29 / $0.33Alpha Vantage | -12.12% miss | DKK 5.54B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.02B | $1.05B | $899.3M | $1.16B |
| Cost of what it sold | $58.0M | $80.8M | $65.2M | $84.0M |
| Gross profit | $964.0M | $974.1M | $834.1M | $1.07B |
| What it spent | ||||
| Research and development | $357.0M | $524.4M | $441.6M | $459.0M |
| Sales and admin | $148.0M | $208.0M | $166.0M | $205.0M |
| Total operating expenses | $505.0M | $731.8M | $608.2M | $664.0M |
| What was left | ||||
| Operating profit | $459.0M | $242.3M | $225.8M | $407.0M |
| Interest on debt | $3.0M | $43.9M | $112.4M | $110.0M |
| Profit before tax | $482.0M | $54.8M | $74.3M | $295.0M |
| Tax | $81.0M | $23.9M | $21.1M | -$8.0M |
| Net profit | $401.0M | $30.9M | $53.2M | $303.0M |
| EBITDA | $503.0M | $98.7M | $186.7M | $431.0M |
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage is bullish
Genmab’s Rina-S Succeeds In First Phase III Trial, Another Win For Late-Stage Portfolio
BullishOct 23Genmab's Rina-S meets phase 3 endpoints in ovarian cancer trial
BullishOct 23Genmab (GMAB) Reports Positive Phase 3 RAINFOL-02 Trial Results for Ovarian Cancer Therapy
BullishOct 23Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
BullishOct 23Funds from operations of Genmab A/S – XETR:GE9
NeutralOct 22GENMAB AS N (GE91.F) Q2 FY2026 earnings call transcript
BullishOct 22Morgan Stanley initiates Genmab stock coverage with Equalweight rating
Leans bullishOct 21Is Genmab (CPSE:GMAB) Undervalued On Fresh DARZALEX Sales Or Is It Already Priced In?
Leans bullishOct 2031 macro signals shaping GMAB right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results
